Guardant Health

Guardant Health nabs FDA test approval for BI's new cancer drug

Boehringer Ingelheim’s Hernexeos has nabbed a companion diagnostic from Guardant Health after the FDA cleared its liquid biopsy test, Guardant360 CDx.

Ben Adams Jun 12, 2026 9:47am

Nuvalent teams up with Guardant Health for companion diagnostics

May 4, 2026 2:48am

Guardant hits the road with colon cancer blood test

Mar 5, 2026 5:50am

Guardant Health gets FDA nod to expand test for colon cancer

Jan 26, 2026 8:15am

Guardant Health pens Merck & Co. cancer collab

Jan 19, 2026 8:10am

Guardant blood test gives early warning of cancer progression

Nov 10, 2025 8:15am